Health Communication

You are here:Home > Posts > Health Communication

Quality medicine information design

With the support of our Donors, Members, and Volunteers from around the world, we are developing  new international guidelines and model templates for consumer medicine information and labelling. Join us.

Better Consumer Medicine Information

Consumer Medicine Information (CMI) in Australia is designed to provide accurate, up-to-date information to consumers about prescription medicines and pharmacy-only medicines. Individual CMI leaflets (CMIs) should provide all the information users might need about a specific medicine product. CMI is provided in the wider context of health information as a communication and counselling link between healthcare providers and medicine consumers. That, at least, is what should happen…

Medicine Label Usability

This Model CRI Project was undertaken to demonstrate how the application of information design methods could lead to better medicine label usability. Along with a later projects, it was instrumental in bringing about a change in the regulations for Over The Counter (OTC) Medicines.

Writing about medicines for people

Medicine information usability guidelines.

Writing about medicines for people is the definitive guidelines for writing, designing, and testing medicine information for consumers.

Now in its third edition, this standard text […]

TGA ignores consumer research

If the draft labelling regulations proposed by TGA are implemented without major change, medicine labelling will become unusable at an acceptable level by at least 50% of literate consumers..

Bad design by TGA

In Australia, where responsibility for government regulation of medicine information is in the hands of the Therapeautic Goods Administration (TGA) we are about to see bad design required by regulation.

Proposed guidelines for medicine labelling won’t work

Suddenly, the Therapeutic Goods Administration (TGA) is an expert in typography and information design. The TGA has proposed a new set of guidelines for medicine labelling, to replace the evidence-based approach in TGO69A and the ASMI Code of Practice. If implemented, the new guidelines will result in more medication errors and a gradual deterioration of medicine labelling usability in Australia.

Why call it the big shift #2

My last blog described how CRI and other communication and information designers have realised that we cannot predict in advance how people will interact with the information we […]

Comments on the TGA Medicine Labelling Review

The issues raised by TGA are legitimate, and the labelling regulations need updating. However, the Consultation Paper ignores the established, evidence-based approach to medicine information design currently enshrined in regulations, and re-introduces an outdated, discredited approach.

Go to Top